Circulating Tumour DNA in Melanoma-Clinic Ready?

Tivey, Ann; Britton, Fiona; Scott, Julie-Ann; Rothwell, Dominic; Lorigan, Paul; Lee, Rebecca

Tivey, Ann; Britton, Fiona; Scott, Julie-Ann; Rothwell, Dominic; Lorigan, Paul; Lee, Rebecca.

Afiliación

Tivey A; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
Britton F; Division of Cancer Sciences, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Scott JA; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
Rothwell D; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
Lorigan P; Division of Cancer Sciences, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Lee R; Nucleic Acids Biomarker Team, Cancer Research UK Manchester Institute, Cancer Biomarker Centre, The University of Manchester, Alderley Park, SK10 4TG, UK.

Curr Oncol Rep ; 24(3): 363-373, 2022 03.

Article en En | MEDLINE | ID: mdl-35133615

Asunto(s)

ADN Tumoral Circulante; Melanoma; Neoplasias Cutáneas; Biomarcadores de Tumor/genética; ADN Tumoral Circulante/genética; Humanos; Melanoma/patología; Recurrencia Local de Neoplasia; Neoplasias Cutáneas/genética; Neoplasias Cutáneas/patología

Palabras clave

Biomarkers; Immunotherapy; Liquid biopsies; Melanoma; Targeted therapy; ctDNA

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / ADN Tumoral Circulante / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google